< Back to situations

[ORGANIZATION]

Ozivy

Featured in 2 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [BR]

Semaglutide regulatory approvals and pricing in Brazil

4 clusters · 79 sources · last updated

Latest: Anvisa approves second generic semaglutide in Brazil

Brazil’s National Health Surveillance Agency (Anvisa) has expanded the domestic market for semaglutide, a medication used to treat type 2 diabetes and weight loss. Initially, Anvisa registered five new semaglutide inject

[QUIET] [BUSINESS] [BR] [CH]

Expansion of semaglutide generic and biosimilar markets

2 clusters · 12 sources · last updated

Latest: Sandoz targets biosimilar growth and generic semaglutide expansion

The pharmaceutical market for semaglutide-based medications is expanding through the introduction of generic and biosimilar alternatives. In Brazil, the National Health Surveillance Agency (Anvisa) approved new injectabl